Acurx Pharmaceuticals Llc Stock Today
| ACXP Stock | USD 0.42 0.01 2.44% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Acurx Pharmaceuticals is selling at 0.42 as of the 23rd of March 2025; that is 2.44 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.42. Acurx Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 21st of February 2025 and ending today, the 23rd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of June 2021 | Category Healthcare | Classification Health Care |
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York. Acurx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 21.76 M outstanding shares of which 213.36 K shares are presently shorted by private and institutional investors with about 1.29 trading days to cover. More on Acurx Pharmaceuticals LLC
Moving together with Acurx Stock
Moving against Acurx Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Acurx Stock Highlights
| President CoFounder | CPA Esq | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Debt LevelsAcurx Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Acurx Pharmaceuticals' financial leverage. It provides some insight into what part of Acurx Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
Acurx Pharmaceuticals LLC (ACXP) is traded on NASDAQ Exchange in USA. It is located in 259 Liberty Avenue, Staten Island, NY, United States, 10305 and employs 4 people. Acurx Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.21 M. Acurx Pharmaceuticals LLC conducts business under Biotechnology sector and is part of Health Care industry. The entity has 21.76 M outstanding shares of which 213.36 K shares are presently shorted by private and institutional investors with about 1.29 trading days to cover.
Acurx Pharmaceuticals LLC currently holds about 9.09 M in cash with (10.38 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Acurx Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAcurx Pharmaceuticals holds a total of 21.76 Million outstanding shares. Acurx Pharmaceuticals LLC shows 11.66 percent of its outstanding shares held by insiders and 9.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Acurx Ownership Details
Acurx Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Renaissance Technologies Corp | 2024-12-31 | 14.7 K | |
| Advisor Group Holdings, Inc. | 2024-12-31 | 14.2 K | |
| Squarepoint Ops Llc | 2024-12-31 | 12.5 K | |
| Patriot Financial Group Insurance Agency, Llc | 2024-12-31 | 10.4 K | |
| Ubs Group Ag | 2024-12-31 | 6 K | |
| Semmax Financial Advisors Inc. | 2024-09-30 | 5.9 K | |
| Tower Research Capital Llc | 2024-12-31 | 4.4 K | |
| Cornerstone Planning Group Llc | 2024-12-31 | 3.3 K | |
| Northwestern Mutual Wealth Management Co | 2024-12-31 | 1.6 K | |
| Vanguard Group Inc | 2024-12-31 | 529.3 K | |
| Prospect Financial Services Llc | 2024-12-31 | 329.1 K |
Acurx Pharmaceuticals Historical Income Statement
Acurx Stock Against Markets
Acurx Pharmaceuticals Corporate Executives
Elected by the shareholders, the Acurx Pharmaceuticals' board of directors comprises two types of representatives: Acurx Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acurx. The board's role is to monitor Acurx Pharmaceuticals' management team and ensure that shareholders' interests are well served. Acurx Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acurx Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert CPA | CoFounder CFO | Profile |
Already Invested in Acurx Pharmaceuticals LLC?
The danger of trading Acurx Pharmaceuticals LLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Acurx Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Acurx Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Acurx Pharmaceuticals LLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.